Schneider National, Inc. (SNDR)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,203	5,129	4,491	4,165	4,781	3,671
Market Cap Growth	-0.26%	14.23%	7.80%	-12.87%	30.23%	-5.01%
Enterprise Value	4,523	5,162	4,665	3,984	4,539	3,164
Last Close Price	23.98	29.05	24.87	22.56	25.61	19.47
PE Ratio	34.26	43.84	18.83	9.10	11.79	17.34
Forward PE	23.66	32.09	21.12	10.28	11.97	14.41
PS Ratio	0.77	0.97	0.82	0.63	0.85	0.81
PB Ratio	1.39	1.72	1.52	1.47	1.97	1.79
P/TBV Ratio	1.79	2.07	1.81	1.66	2.29	1.99
P/FCF Ratio	25.55	34.94	-	25.59	187.48	18.43
P/OCF Ratio	6.24	7.48	6.60	4.86	8.45	5.94
PEG Ratio	0.63	-	-	1.48	0.46	2.08
EV/Sales Ratio	0.83	0.98	0.85	0.60	0.81	0.70
EV/EBITDA Ratio	7.71	9.41	7.18	4.06	5.53	5.58
EV/EBIT Ratio	24.48	30.87	15.69	6.06	8.31	10.82
EV/FCF Ratio	27.50	35.16	-	24.47	177.98	15.88
Debt / Equity Ratio	0.17	0.20	0.10	0.08	0.11	0.15
Debt / EBITDA Ratio	0.83	1.03	0.46	0.22	0.33	0.54
Debt / FCF Ratio	3.20	4.16	-	1.32	10.60	1.54
Asset Turnover	1.15	1.12	1.24	1.60	1.51	1.27
Inventory Turnover	52.51	42.71	53.33	132.68	125.89	64.68
Quick Ratio	1.59	1.32	1.51	1.94	1.71	2.09
Current Ratio	1.91	1.58	1.83	2.12	1.81	2.28
Return on Equity (ROE)	4.20%	3.94%	8.23%	17.40%	18.10%	9.87%
Return on Assets (ROA)	2.43%	2.20%	4.19%	9.96%	9.16%	5.09%
Return on Capital (ROIC)	3.42%	3.05%	5.89%	14.31%	13.50%	7.25%
Return on Capital Employed (ROCE)	4.30%	4.00%	7.50%	17.90%	16.80%	9.80%
Earnings Yield	2.98%	2.28%	5.31%	10.99%	8.48%	5.77%
FCF Yield	3.91%	2.86%	-2.84%	3.91%	0.53%	5.43%
Dividend Yield	1.58%	1.31%	1.45%	1.42%	1.25%	1.34%
Payout Ratio	54.28%	56.92%	26.67%	12.17%	12.23%	21.40%
Buyback Yield / Dilution	0.54%	1.18%	0.34%	-0.39%	-0.28%	-0.17%
Total Shareholder Return	2.12%	2.49%	1.78%	1.03%	0.97%	1.17%

Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q